Genmab reported DKK9.07B in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Agios Pharmaceuticals AGIO:US $ 203.13M 197.1M
AstraZeneca AZN:LN 6329M 738M
Bayer BAYN:GR € 4564M 248M
Bluebird Bio BLUE:US $ 396.62M 5.84M
Genmab GEN:DC DK 9071M 114M
GRIFOLS GRF:SM € 397.86M 16.88M
Hikma Pharmaceutical HIK:LN 426M 424M
Immunogen IMGN:US $ 437.66M 41.09M
Lonza Group LONN:SW 1.58B 1.08B
Novartis NOVN:VX SF 12407M 5196M